Omidenepag isopropyl 0.02 MG/ML Ophthalmic Solution — RxCUI 2612702
RxNorm drug concept · Semantic clinical drug
RxCUI 2612702
Semantic clinical drug · SCD
● Current RxNorm concept 1 FDA product
2 package NDCs
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI2612702
Official nameOmidenepag isopropyl 0.02 MG/ML Ophthalmic Solution
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known asomidenepag isopropyl 0.002 % Ophthalmic Solution
FDA products mapped1
Package NDCs mapped2
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
🕸️ Concept Web — How Omidenepag isopropyl 0.02 MG/ML Ophthalmic Solut... Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
Omidenepag isopropyl 0.02 MG/ML Ophthalmic Solution
RxCUI 2612702 Semantic clinical drug · SCD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 2
The active substance itself — no strength, form, or brand attached yet.
-
Omidenepag
2612691IN -
Omidenepag isopropyl
2612690PIN
-
Omidenepag
-
Brand names 1
The same medicine's trade names. A brand name alone says nothing about strength or form.
-
Omlonti
2612696BN
-
Omlonti
-
Dose forms 9
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Omidenepag Ophthalmic Solution
2612701SCDF -
Omidenepag isopropyl Ophthalmic Solution
2645861SCDFP -
Omidenepag Ophthalmic Product
2612693SCDG -
Omidenepag isopropyl Ophthalmic Product
2660594SCDGP -
Omidenepag Ophthalmic Solution [Omlonti]
2612703SBDF -
Omidenepag isopropyl Ophthalmic Solution [Omlonti]
2654368SBDFP -
Omlonti Ophthalmic Product
2612698SBDG -
Ophthalmic Solution
7670DF - +1 more in this family
-
Omidenepag Ophthalmic Solution
-
Clinical & branded drugs 3
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
Omidenepag isopropyl 0.02 MG/ML
2612692SCDC -
Omidenepag isopropyl 0.02 MG/ML Ophthalmic Solution [Omlonti]
2612704SBD -
Omidenepag isopropyl 0.02 MG/ML [Omlonti]
2612697SBDC
-
Omidenepag isopropyl 0.02 MG/ML
Showing up to 8 concepts per family — 14 of 15 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
Omidenepag isopropyl 0.02 MG/ML
SCDC · 2612692 -
Omidenepag Ophthalmic Solution
SCDF · 2612701 -
Omidenepag isopropyl Ophthalmic Solution
SCDFP · 2645861 -
Omidenepag Ophthalmic Product
SCDG · 2612693 -
Omidenepag isopropyl Ophthalmic Product
SCDGP · 2660594
Brand-Name Concepts
-
Omidenepag isopropyl 0.02 MG/ML Ophthalmic Solution [Omlonti]
SBD · 2612704 -
Omidenepag isopropyl 0.02 MG/ML [Omlonti]
SBDC · 2612697 -
Omidenepag Ophthalmic Solution [Omlonti]
SBDF · 2612703 -
Omidenepag isopropyl Ophthalmic Solution [Omlonti]
SBDFP · 2654368 -
Omlonti Ophthalmic Product
SBDG · 2612698 -
Omlonti
BN · 2612696
📦 FDA Products & Package NDCs
1 product · 2 package NDCs
2 package NDCs map to RxCUI 2612702 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 84826-0002-01 | 1 BOTTLE, PLASTIC in 1 CARTON (84826-002-01) / 2.5 mL in 1... | Omlonti | Ocuvex Therapeutics, Inc. | 2025-04-28 |
| 84826-0002-03 | 3 BOTTLE, PLASTIC in 1 CARTON (84826-002-03) / 2.5 mL in 1... | Omlonti | Ocuvex Therapeutics, Inc. | 2025-04-28 |
Observed labelers:
Ocuvex Therapeutics, Inc. (2)
— this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.